期刊文献+

聚乙二醇修饰聚酰胺-胺的合成、表征及其人角膜上皮细胞毒性 被引量:1

Synthesis,characterization of PEG-PAMAM and their cytotoxicity in human corneal epithelial cells
原文传递
导出
摘要 目的:研究不同相对分子质量聚乙二醇(PEG)修饰不同代数树枝状大分子聚酰胺-胺(PAM-AM)得到的产物,测定其对人体角膜上皮细胞(HCECs)的毒性。方法:采用硝基苯氯甲酸酯(p-NPC)将单甲氧基聚乙二醇(mPEG,相对分子质量为750,2 000,5 000)活化成PEG碳酸酯,对第4,5代PAMAM大分子进行修饰;目标产物用FT-IR、1H-NMR进行结构表征;采用WST-8法考察PEG修饰对PAMAM的人角膜上皮细胞(HCECs)毒性的影响。结果:PAMAM经较低浓度PEG修饰后,对HCECs的毒性减弱不明显,经较高浓度PEG修饰后,对HCECs减毒明显减弱,不同相对分子质量的PEG修饰对PAMAM的减毒作用无明显差异。结论:经PEG修饰后,可以降低PAMAM对HCECs的毒性,作为新型眼部给药载体具有良好的前景。 Objective: To investigate the eytotoxie effeets of PAMAMG4, G5 that are modified by polyethylene glyeol (PEG) in human corneal epithelial eells (HCECs). Methods: Methoxy PEG (MW = 750, 2 000 and 5 000) were activated to carbonates by p-nitrophenyl ehloroformate, and used to modify PAMAM for forming PAM- AMG4.G5. The produets were eharaeterized by FT-IR and ^1H-NMR. Then, we detected their toxicity to HCECs by WST-8 assay. Results: Compared to PAMAM, the modified PAMAM by PEG manifested lower eytotoxicity at low eoncentritions, but obviously higher at high eoncentritions. The reduetion in eytotoxieity of the modified PAMAM by each molecular weight PEG little differed. Conclusion: The modified PAMAM by PEG seems to be a very promising drug delivery system due to their little cytotoxieity to human corneal epithelial eells.
机构地区 烟台大学药学院
出处 《中国新药杂志》 CAS CSCD 北大核心 2012年第6期686-689,共4页 Chinese Journal of New Drugs
基金 国家自然科学基金(30873447)
关键词 聚乙二醇 聚酰胺-胺 角膜上皮细胞 毒性 PEG PAMAM corneal epithelial ceils toxieity
  • 相关文献

参考文献20

  • 1ESFAND R,TOMALIA DA.Poly(amidoamine)(PAMAM)dendrimers:from biomimicry to drug delivery and biomedical ap-plications[J].Drug Discov Today,2001,6(8):427-436.
  • 2AULENTA F,HAYES W,RANNARD S.Dendrimers:a newclass of nanoscopic containers and delivery devices[J].EurPolym J,2003,39(9):1741-1771.
  • 3PATRI AK,KUKOWSKA-LATALLO JF,BAKER JR JR.Targe-ted drug delivery with dendrimers:comparison of the release kinet-ics of covalently conjugated drug and non-covalent drug inclusioncomplex[J].Adv Drug Deliv Rev,2005,57(15):2203-2214.
  • 4TOMALIA DA,REYNA LA,SVENSON S.Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic im-aging[J].Biochem Soc Trans,2007,35(1):61-67.
  • 5VENDITTO VJ,REGINO CAS,BRECHBIEL MW,et al.PAM-AM dendrimer based macromolecules as improved contrast agents[J].Mol Pharm,2005,2(4):302-311.
  • 6陆珺珺,吴正红,平其能.聚酰胺-胺PAMAM树状聚合物对灯盏花素的溶解性及其药代动力学的影响[J].药学学报,2009,44(2):197-202. 被引量:7
  • 7ROBISON JR ED.Ophthalmic drug delivery system[J].Wash-ington DC:American Pharmaceutical Association,1980:1.
  • 8URTTI A.Challenges and obstacles of ocular pharmacokineticsand drug delivery[J].Adv Drug Deliv Rev,2006,58(11):1131-1135.
  • 9YAO WJ,SUN KX,MU HJ,et al.Preparation and characteriza-tion of puerarin-dendrimer complexes as an ocular drug deliverysystem[J].Drug Dev Ind Pharm,2010,36(9):1027-1035.
  • 10YAO WJ,SUN KX,LIU Y,et al.Effect of poly(amidoamine)dendrimers on corneal penetration of puerarin[J].Biol PharmBull,2010,33(8):1371-1377.

二级参考文献23

  • 1孙考祥,王爱萍,黄丽军,梁荣才,刘珂.双氯酚酸钠脂质体的制备及其眼部药代动力学[J].药学学报,2006,41(11):1094-1098. 被引量:15
  • 2Ali Y.,Lehussaari K..Adv.Drug Deliv.Rev.[J],2006,58(11):1258-1268.
  • 3Sahoo S.K.,Dilnawaz F.,Krishnakumar S..Drug Discovery Today[J],2008,13(3/4):144-151.
  • 4Malik N.,Wiwattanapatapee R.,Klopsch R.,et al..J.Controlled Release[J],2000,65:133-148.
  • 5Roberts J.C.,Bhalgat M.K.,Zera R.T..J.Biomed.Mater.Res.[J],1996,30(1):53-65.
  • 6Kitchens K.M.,Kolhatkar R.B.,Swaan P.W.,et al..Pharm.Res.[J],2006,23(12):2818-2826.
  • 7Jevprasesphant R.,Penny J.,Attwood D.,et al..Pharm.Res.[J],2003,20(10):1543-1550.
  • 8Chandrasekar D.,Sistla R.,Diwan P.V.,et al..Biomaterials[J],2007,28(3):504-512.
  • 9Purohit G.,Sakthivel T.,Florence A.T..International Journal of Pharmaceutics[J],2001,214(1/2):71-76.
  • 10Klajnert B.,Epand R.M..International Journal of Pharmaceutics[J],2005,305(1/2):154-166.

共引文献18

同被引文献9

  • 1TOMALIA DA. Birth of a new macromolecular architecture:den- drimers as quantized building blocks for nanoscale synthetic poly- mer chemistry[ J ]. Progress in Polymer Science, 2005,30 ( 3 - 4) :294 - 324.
  • 2PATIL ML,ZHANG M, MINKO T. Multifunctional triblock nano- carrier(PAMAM-PEG-PLL) for the efficient intracellulai" siRNA delivery and gene silencing [ J ]. ACS Nano ,2011,5 ( 3 ) : 1877 - 1887.
  • 3HU XL,LI H,LUO SZ,et al. Thiol and pH dual-responsive dy- namic covalent shell cross-linked mieelles for triggered release of chemotherapeutic drugs[J]. Polym Chem,2013,4(3) :695 -706.
  • 4QIU L, LI Z, QIAO M,et al. Self-assembled pH-responsive hyal- uronic acid-g-poly (L-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin[ J]. Acta Biomater ,2014 ,10 (5) :2024 - 2035.
  • 5HONG W, CHEN D,JIA L,et al. Thermo- and pH-responsive co- polymers based on PLGA-PEG-PLGA and poly (L-Histidine): synthesis and in vitro characterization of copolymermicelles [ J ]. Acta Biomater,2014 ,10 (3) : 1259 - 1271.
  • 6WEN Y,GUO Z, DU Z,et al. Serum tolerance and endosomal es- cape capacity of histidine-modified pDNA-loaded complexes based on polyamidoamine dendrimer derivatives [ J]. Biomateri- als,2012,33(32) :8111 -8121.
  • 7WANG Y, CAO XY, GUO R, et al. Targeted delivery of doxorubi- cin into cancer ceils using a folic aeld-dendrimer conjugate [ J ]. Polymer Chemistry,2011,2 ( 8 ) : 1754 - 1760.
  • 8HAN L, HUANG RQ, LIU SH, et al. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overex- pressed tumors [ J ]. Molecular Pharmaceutics, 2010, 7 ( 6 ) : 2156 -2165.
  • 9郭玲香,高秋端.赖氨酸修饰聚酰胺-胺树枝状高分子的制备及性能[J].高等学校化学学报,2012,33(1):176-181. 被引量:4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部